Predicting Clinical Dementia Rating Using Blood RNA Levels
The Clinical Dementia Rating (CDR) is commonly used to assess cognitive decline in Alzheimer’s disease patients and is included in the Alzheimer’s Disease Neuroimaging Initiative (ADNI) dataset. We divided 741 ADNI participants with blood microarray data into three groups based on their most recent...
Main Authors: | Justin B. Miller, John S. K. Kauwe |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-06-01
|
Series: | Genes |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4425/11/6/706 |
Similar Items
-
Investigating Sterol and Redox Regulation of the Ion Channel Activity of CLIC1 Using Tethered Bilayer Membranes
by: Heba Al Khamici, et al.
Published: (2016-12-01) -
CLIC1 Protein Accumulates in Circulating Monocyte Membrane during Neurodegeneration
by: Valentina Carlini, et al.
Published: (2020-02-01) -
Predicting Prodromal Dementia Using Linguistic Patterns and Deficits
by: Ahmed H. Alkenani, et al.
Published: (2020-01-01) -
Transmembrane Chloride Intracellular Channel 1 (tmCLIC1) as a Potential Biomarker for Personalized Medicine
by: Francesca Cianci, et al.
Published: (2021-07-01) -
Clinical Approach to Diagnosis of Pre-Dementia Alzheimer’s Disease (CAD-PAD)
by: J. Alom, et al.
Published: (2012-08-01)